International Congress on Advanced Cardiology and Cardiovascular Research

Scope & Importance

Cardiology is a rapidly evolving subfield of medicine. People in this era, both young and elderly, are vulnerable to cardiac diseases, which are primarily caused by their lifestyle and poor hygiene. To combat these diseases and their causes, the study of cardiology has grown in importance over time. Interventional cardiology is a branch of cardiology that uses minimally invasive procedures to treat diseases with the use of a catheter, allowing doctors and patients to complete the surgery with less blood loss and minimal risk.

Some scientific advances in the fields of sciences, interventional cardiology, and cryopreservation are also predicted to drive the cardiac surgery devices market. The use of expanded Polytetrafluoroethylene for cardiovascular patches, the introduction of transcatheter heart valves, and thus the process of minimally invasive technologies, such as transcatheter semi-lunar valve implantation or transcatheter aortic valve replacement, are just a few of the factors that are expected to drive growth over the forecast period. Furthermore, changes in cryopreservation technologies by key players like CryoLife are among major technological breakthroughs in cardiac surgery therapies that are expected to positively influence the market.

The presence of technologically advanced cardiology and cardiovascular valves, grafts, and patches, as well as an increase in the generality of congenital heart defects, are among the basic variables projected to drive development over the forecast period. During the projection period of 2017-2023, the global market for heart transplants is expected to develop at a CAGR (Compound Annual Growth Rate) of 11.2 percent. The global Interventional Cardiology market is expected to develop slowly at a CAGR of almost 7% during the forecast period. The increased need for minimally invasive (MI) procedures will boost the global interventional cardiology market's growth prospects in the future years.The global interventional cardiology devices market is expected to be worth USD 21.2 billion by 2025, up from USD 13.8 billion in 2020, at an 8.9 percent CAGR during the forecast period. The significant rise in the geriatric population, prevalence of coronary artery diseases, the approval of new and sophisticated products, and thus the rising incidence of diabetes, are all driving growth in this industry.

Cardiology Market in Asia-Pacific:

The Asia Pacific interventional cardiology market is expected to increase at a 7.9 percent CAGR from 2017 to 2023. Cardiac monitoring and diagnostic market size in Asia is 4.5 billion USD in 2015, rising to 6 billion USD in 2017 with an 8% growth rate, and expected to reach 12 billion USD by 2023.

According to the International Diabetes Federation, Asia is home to 60% of the world's diabetes population. Diabetes is one of the leading causes of cardiovascular disease. The rising prevalence of cardiovascular illnesses is the primary driver of market growth in Asia Pacific. Aside from the rising prevalence of diabetes and obesity, changes in lifestyle, more public awareness, and quick technological advancements all contributed to the market's expansion. On the other hand, high cost for manufacturing the devices and a lot of barriers for the course of the new device are the main restraints hampering the market growth.

Cardiology Market in Europe:

The Europe region market for Cardiology management devices, Aortic Repair devices, transcatheter embolization and occlusion devices will grow through 2026, driven by factors such as an ageing population, sedentary lifestyle and changes in food habits, advancements in the field of cardiology as well as an increase in the number of interventional cardiologists, and increasing demand for surgical occlusion devices.

Cardiology Market in America:

Geographically, North America has the highest market share in 2019 due to increased awareness of gut illnesses. According to the Centers for Disease Control and Prevention (CDC), approximately 610,000 Americans die of heart disease each year. Similarly, 735,000 Americans die of heart attacks each year. Thus, an increase in heart attacks in North America would increase the demand for cardiovascular drugs. However, Asia-Pacific region is predicted to showcase the fastest rate of growth within the future due to the rise in the aging population, increasing awareness and other factors.

Cardiology Market in Middle East:

Countries in the Middle East and Africa bear an important burden from Ischemic heart conditions. Consistent with Dubai Health Authority, heart condition is the cause for each 3 in 10 deaths within the UAE. Huge funding in R&D and various initiatives by the government is driving the expansion of the Ischemic heart condition market in the Middle East and Africa. The Middle-East and Africa Ischemic heart condition market is growing steadily. The market is growing at the CAGR of three .1% and expected to succeed in to US$ 2.84 billion by 2022.

Future Cardiology reflects this new era of cardiology and highlights the new molecular approach to advancing cardiovascular therapy. Coverage also will reflect the main technological advances in bioengineering in cardiology in terms of advanced and robust devices, miniaturization, imaging, system modeling and knowledge management issues.